6c3fd2dd__Trials_Monthly___October_2013__Description
[NCI Designation] NCT01799278 [Disease Site] Prostate Cancer [Description] 
A Phase II Trial of the Aurora Kinase A Inhibitor MLN8237 in Patients with Metastatic Castrate Resistant and Neuroendocrine Prostate Cancer
Seattle Cancer Care Alliance | Clinical Trials Monthly - October 2013
Description